BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Simó R, Bogdanov P, Ramos H, Huerta J, Simó-Servat O, Hernández C. Effects of the Topical Administration of Semaglutide on Retinal Neuroinflammation and Vascular Leakage in Experimental Diabetes. Biomedicines 2021;9:926. [PMID: 34440130 DOI: 10.3390/biomedicines9080926] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Takase K, Yokota H, Ohno A, Watanabe M, Kushiyama A, Kushiyama S, Yamagami S, Nagaoka T. A pilot study of diabetic retinopathy in a porcine model of maturity onset diabetes of the young type 3 (MODY3). Exp Eye Res 2023;227:109379. [PMID: 36608813 DOI: 10.1016/j.exer.2022.109379] [Reference Citation Analysis]
2 Wołos-kłosowicz K, Matuszewski W, Rutkowska J, Krankowska K, Bandurska-stankiewicz E. Will GLP-1 Analogues and SGLT-2 Inhibitors Become New Game Changers for Diabetic Retinopathy? JCM 2022;11:6183. [DOI: 10.3390/jcm11206183] [Reference Citation Analysis]
3 Feldman-billard S, Halimi S. Nouveaux traitements du diabète de type 2 et rétinopathie diabétique. Médecine des Maladies Métaboliques 2022. [DOI: 10.1016/j.mmm.2022.08.007] [Reference Citation Analysis]
4 Ren J, Zhang S, Pan Y, Jin M, Li J, Luo Y, Sun X, Li G. Diabetic retinopathy: Involved cells, biomarkers, and treatments. Front Pharmacol 2022;13:953691. [DOI: 10.3389/fphar.2022.953691] [Reference Citation Analysis]
5 Bogdanov P, Ramos H, Valeri M, Deàs-just A, Huerta J, Simó R, Hernández C. Minimum Effective Dose of DPP-4 Inhibitors for Treating Early Stages of Diabetic Retinopathy in an Experimental Model. Biomedicines 2022;10:465. [DOI: 10.3390/biomedicines10020465] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Jiang Z, Tan J, Yuan Y, Shen J, Chen Y. Semaglutide ameliorates lipopolysaccharide-induced acute lung injury through inhibiting HDAC5-mediated activation of NF-κB signaling pathway. Hum Exp Toxicol 2022;41:9603271221125931. [PMID: 36075570 DOI: 10.1177/09603271221125931] [Reference Citation Analysis]
7 Arendt Nielsen T, Sega R, Uggerhøj Andersen C, Vorum H, Mohr Drewes A, Jakobsen PE, Brock B, Brock C. Liraglutide Treatment Does Not Induce Changes in the Peripapillary Retinal Nerve Fiber Layer Thickness in Patients with Diabetic Retinopathy. J Ocul Pharmacol Ther 2021. [PMID: 34918951 DOI: 10.1089/jop.2021.0055] [Reference Citation Analysis]